Results 21 to 30 of about 2,775,704 (206)

Study on the change of neutralizing antibody level in plasma donors after a third shot of inactivated novel coronavirus vaccine

Zhongguo shuxue zazhi, 2023
Objective To investigate the trend of neutralizing antibody level in plasma donors who received the 3rd shot of inactivated novel coronavirus vaccine.
Wenjuan GE, An ZHOU, Junying SHEN, Xiaoqing LI, Jie MA, Mengzhao ZHU, Changyong JIAN   +6 more
doaj   +1 more source

Selection of sterilizing-grade filter for preparation of human coagulation factor Ⅷ/ von Willebrand factor complex

Zhongguo shuxue zazhi, 2023
Objective To screen the sterilizing-grade filters applicable for production of human coagulation factor Ⅷ/von Willebrand factor complex(FⅧ/VWF)and study the sterilization filtration process.
Quanjuan GUO, An ZHOU, Wenjie LIU, Yike XU, Wenqiang SHI, Chen CHEN, Changyong JIAN   +6 more
doaj   +1 more source

Development and Preliminary Application of a Droplet Digital PCR Assay for Quantifying the Oncolytic Herpes Simplex Virus Type 1 in the Clinical-Grade Production

Viruses, 2023
Oncolytic herpes simplex virus (oHSV) is a type of virus that selectively targets and kills cancer cells, leaving normal cells unharmed. Accurate viral titer is of great importance for the production and application of oHSV products. Droplet digital PCR (
Miaomiao Guo, Li Deng, Hongyang Liang, Yuyao Du, Wenrui Gao, Na Tian, Ying Bi, Jinghua Li, Tiancong Ma, Yuntao Zhang, Hui Wang   +10 more
doaj   +1 more source

Pharmacovigilance of Biosimilars [PDF]

, 2013
In lieu of an abstract, here is the article\u27s first paragraph: Biotech industry forms the backbone of the current pharmaceutical products. Seven out of top ten anticipated drugs of the industry in 2014 will be biologics [1].
Chablani, Lipika
core   +2 more sources

Comparative Study on MNVT of OPV Type I and III Reference Products in Different Periods

Diseases, 2023
Widespread vaccination using the oral live attenuated polio vaccine (OPV) and Sabin strain inactivated vaccine (sIPV) have greatly reduced the incidence of polio worldwide.
Xiyan Wang, Ruirui Ren, Bo Ma, Jing Xie, Yan Ma, Hong Luo, Yu Guo, Ling Ding, Liang Zhang, Mengyuan Zhang, Tianlang Wang, Zhichao Shuang, Xiujuan Zhu   +12 more
doaj   +1 more source

Virological Characteristics of Five SARS-CoV-2 Variants, Including Beta, Delta and Omicron BA.1, BA.2, BA.5

Viruses, 2023
SARS-CoV-2 variants of concern (VOCs) show increasing transmissibility and infectivity and induce substantial injuries to human health and the ecology. Therefore, it is vital to understand the related features for controlling infection.
Yan Zeng, Fei Xia, Changfu Guo, Chunxia Hu, Yuwei Li, Xiang Wang, Qin Wu, Zhuo Chen, Jia Lu, Zejun Wang   +9 more
doaj   +1 more source

Identification of a Conserved, Linear Epitope on VP3 of Enterovirus A Species Recognized by a Broad-Spectrum Monoclonal Antibody

Viruses, 2023
Outbreaks of hand, foot and mouth disease (HFMD) have occurred frequently in the Asian-Pacific region over the last two decades, caused mainly by the serotypes in Enterovirus A species.
Lie Fu, Xiao-Yu Zhang, Wei-Ping Jin, Chen Wang, Sha-Sha Qian, Meng-Jun Wang, Wen-Hui Wang, Sheng-Li Meng, Jing Guo, Ze-Jun Wang, Xiao-Qi Chen, Shuo Shen   +11 more
doaj   +1 more source

Validation of the detection method for residual human coagulation factor Ⅺ in human prothrombin complex

Zhongguo shuxue zazhi, 2023
Objective To establish an enzyme-linked immunosorbent assay (ELISA) method for the determination of residual human coagulation factor Ⅺ in human prothrombin complex and validate the method.
Yong LIU, Yurong YU, Long YANG, Zexiu LI, Yao ZHANG, Jing DENG, Dan LI, Yunhua CHEN, Xuemei ZHAO   +8 more
doaj   +1 more source

100 years of microbial electricity production : three concepts for the future [PDF]

, 2012
Bioelectrochemical systems (BES) have been explored according to three main concepts: to produce energy from organic substrates, to generate products and to provide specific environmental services.
Arends, Jan, Verstraete, Willy
core   +2 more sources

Safety and immunogenicity of a quadrivalent influenza vaccine in adults aged 60 years or above: a phase III randomized controlled clinical study

Human Vaccines & Immunotherapeutics, 2022
To control seasonal influenza epidemics in elders, a quadrivalent, inactivated, split-virion influenza vaccine (IIV4) comprising A and B lineages is produced for young individuals and adults aged ≥60 years.
Renfeng Fan, Xiaoyuan Huang, Xuanxuan Nian, Zhiqiang Ou, Jian Zhou, Jiayou Zhang, Peiyu Zeng, Wei Zhao, Jinglong Deng, Wei Chen, Shaomin Chen, Kai Duan, Yingshi Chen, Xinguo Li, Jikai Zhang, Xiaoming Yang   +15 more
doaj   +1 more source